C12N2760/20141

CORONAVIRUS DISEASE (COVID-19) VACCINE

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.

Coronavirus disease (COVID-19) vaccine

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.

Coronavirus disease (COVID-19) vaccine

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.

Coronavirus disease (COVID-19) vaccine

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.